A multicenter, randomized, double-blind study of ulimorelin and metoclopramide in the treatment of critically ill patients with enteral feeding intolerance: PROMOTE trial
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
PurposeEnteral feeding intolerance (EFI) is a frequent problem in the intensive care unit (ICU), but current prokinetic agents have uncertain efficacy and safety profiles. The current study compared the efficacy and safety of ulimorelin, a ghrelin agonist, with metoclopramide in the treatment of EFI.MethodsOne hundred twenty ICU patients were randomized 1:1 to ulimorelin or metoclopramide for 5 days. EFI was diagnosed by a gastric residual volume (GRV) ≥ 500 ml. A volume-based feeding protocol was employed, and enteral formulas were standardized. The primary end point was the percentage daily protein prescription (%DPP) received by patients over 5 days of treatment. Secondary end points included feeding success, defined as 80% DPP; gastric emptying, assessed by paracetamol absorption; incidences of recurrent intolerance (GRV ≥ 500 ml); vomiting or regurgitation; aspiration, defined by positive tracheal aspirates for pepsin; and pulmonary infection.ResultsOne hundred twenty patients were randomized and received the study drug (ulimorelin 62, metoclopramide 58). Mean APACHE II and SOFA scores were 21.6 and 8.6, and 63.3% of patients had medical reasons for ICU admission. Ulimorelin and metoclopramide resulted in comparable %DPPs over 5 days of treatment (median [Q1, Q3]: 82.9% [38.4%, 100.2%] and 82.3% [65.6%, 100.2%], respectively, p = 0.49). Five-day rates of feeding success were 67.7% and 70.6% when terminations unrelated to feeding were excluded, and there were no differences in any secondary outcomes or adverse events between the two groups.ConclusionsBoth prokinetic agents achieved similar rates of feeding success, and no safety differences between the two treatment groups were observed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McClave, S. A., Taylor, B. E., Martindale, R. G., Warren, M. M., Johnson, D. R., Braunschweig, C., McCarthy, M. S., Davanos, E., Rice, T. W., Cresci, G. A., et al. (2016) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607115621863 · Cited by 3,982
ESPEN guideline on clinical nutrition in the intensive care unit.
Singer, P., Blaser, A. R., Berger, M. M., Alhazzani, W., Calder, P. C., Casaer, M. P., Hiesmayr, M., Mayer, K., Montejo, J. C., Pichard, C., et al. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.08.037 · Cited by 2,904
Self-citationTaylor, B. E., McClave, S. A., Martindale, R. G., Warren, M. M., Johnson, D. R., Braunschweig, C., McCarthy, M. S., Davanos, E., Rice, T. W., Cresci, G. A., et al. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001525 · Cited by 1,476
Early enteral nutrition in critically ill patients: ESICM clinical practice guidelines
ESICM Working Group on Gastrointestinal Function, Reintam Blaser, A., Starkopf, J., Alhazzani, W., Berger, M. M., Casaer, M. P., Deane, A. M., Fruhwald, S., Hiesmayr, M., Ichai, C., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-016-4665-0 · Cited by 837
Temel, J. S., Abernethy, A. P., Currow, D. C., Friend, J., Duus, E. M., Yan, Y., & Fearon, K. C. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00558-6 · Cited by 639
Reignier, J., Boisramé-Helms, J., Brisard, L., Lascarrou, J.-B., Ait Hssain, A., Anguel, N., Argaud, L., Asehnoune, K., Asfar, P., Bellec, F., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32146-3 · Cited by 595
Nicolo, M., Heyland, D. K., Chittams, J., Sammarco, T., & Compher, C. (2016) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607115583675 · Cited by 294
Self-citationBLASER, A. R., STARKOPF, J., KIRSIMÄGI, Ü., & DEANE, A. M. (2014) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.12302 · Cited by 231
Universal equation for estimating ideal body weight and body weight at any BMI
Peterson, C. M., Thomas, D. M., Blackburn, G. L., & Heymsfield, S. B. (2016) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.121178 · Cited by 175
Actions and therapeutic pathways of ghrelin for gastrointestinal disorders
Camilleri, M., Papathanasopoulos, A., & Odunsi, S. T. (2009) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.72 · Cited by 115
Cited by
Heyland, D. K., Ortiz, A., Stoppe, C., Patel, J. J., Yeh, D. D., Dukes, G., Chen, Y. J., Almansa, C., & Day, A. G. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000004712 · Cited by 201
“In recent trials, one randomized to prokinetic use after a single episode of EFI and failed to show any difference, whereas a trial requiring two consecutive EFI episodes showed some benefit (10,11).”
BackgroundSelf-citationEnteral Feeding Intolerance: Updates in Definitions and Pathophysiology
Reintam Blaser, A., Deane, A. M., Preiser, J., Arabi, Y. M., & Jakob, S. M. (2021) · Nutrition in Clinical Practice · doi:10.1002/ncp.10599 · Cited by 156
Use of prokinetic agents in hospitalised adult patients: A scoping review
Crone, V., Møller, M. H., Bækgaard, E. S., Perner, A., Bytzer, P., Alhazzani, W., & Krag, M. (2023) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.14222 · Cited by 15
Metadata
- Authors
- Heyland, D. K., van Zanten, A. R. H., Grau-Carmona, T., Evans, D., Beishuizen, A., Schouten, J., Hoiting, O., Bordejé, M. L., Krell, K., Klein, D. J., Gonzalez, J., Perez, A., Brown, R., James, J., Harris, M. S., the Investigators of the PROMOTE LP101-CL-201 Trial, Heyland, D. K., Evans, D. C., Jolley, S., Raines, R., Krell, K., Falls, I., Grau-Carmona, T., Serviá-Goixart, L., Perez-Quesada, S., Herrero-Meseguer, J. I., Calvo-Herranz, E., Lorencio, C., Peredes, A., Yébenes-Reyes, J. C., Garcia-Martinez, M. A., Cervera, M., Bordejé, M. L., Fernadez-Ortega, J. F., Fernández-González, I., van Zanten, A., Beishuizen, A., Schouten, J., Hoiting, O., Wilhelmina, C., Stelfox, T., & Posadas, J.
- Venue
- Intensive Care Medicine
- Published
- 2019-05-01
- Volume
- 45
- Issue
- 5
- Pages
- 647-656
- ISSN
- 0342-4642 (ISSN-L)
- 1432-1238
- OpenAlex
- W2943965773
- Cited by
- 41
- References
- 11
- FWCI
- 4.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.